Disease history and risk of comorbidity in women's life course : a comprehensive analysis of the Japan Nurses’ Health Study baseline survey by Nagai, Kazue et al.
Disease history and risk of
comorbidity in women’s life course:
a comprehensive analysis of the Japan
Nurses’ Health Study baseline survey
Kazue Nagai,1 Kunihiko Hayashi,1 Toshiyuki Yasui,2 Kota Katanoda,3
Hiroyasu Iso,4 Yutaka Kiyohara,5 Akihiko Wakatsuki,6 Toshiro Kubota,7
Hideki Mizunuma8
To cite: Nagai K, Hayashi K,
Yasui T, et al. Disease history
and risk of comorbidity in
women’s life course:
a comprehensive analysis of
the Japan Nurses’ Health




▸ Prepublication history for
this paper is available online.
To view these files please
visit the journal online
(http://dx.doi.org/10.1136/
bmjopen-2014-006360).
Received 14 August 2014
Revised 26 December 2014
Accepted 1 February 2015






Objective: To classify diseases based on age at peak
incidence to identify risk factors for later disease in
women’s life course.
Design: A cross-sectional baseline survey of
participants in the Japan Nurses’ Health Study.
Setting: A nationwide prospective cohort study on the
health of Japanese nurses. The baseline survey was
conducted between 2001 and 2007 (n=49 927).
Main outcome measures: Age at peak incidence for
20 diseases from a survey of Japanese women was
estimated using the Kaplan-Meier method with the Kernel
smoothing technique. The incidence rate and peak
incidence for diseases whose peak incidence occurred
before the age of 45 years or before the perimenopausal
period were selected as early-onset diseases. The OR and
95% CI were estimated to examine the risk of
comorbidity between early-onset and other diseases.
Results: Four early-onset diseases (endometriosis,
anaemia, migraine headache and uterine myoma) were
significantly correlated with one another. Late-onset
diseases significantly associated (OR>2) with early-onset
diseases included comorbid endometriosis with ovarian
cancer (3.65 (2.16 to 6.19)), endometrial cancer (2.40
(1.14 to 5.04)) and cerebral infarction (2.10 (1.15 to
3.85)); comorbid anaemia with gastric cancer (3.69 (2.68
to 5.08)); comorbid migraine with transient ischaemic
attack (3.06 (2.29 to 4.09)), osteoporosis (2.11 (1.71 to
2.62)), cerebral infarction (2.04 (1.26 to 3.30)) and angina
pectoris (2.00 (1.49 to 2.67)); and comorbid uterine
myoma with colorectal cancer (2.31 (1.48 to 3.61)).
Conclusions:While there were significant associations
between four early-onset diseases, women with a history
of one or more of the early-onset diseases had a higher
risk of other diseases later in their life course.
Understanding the history of early-onset diseases in
women may help reduce the subsequent risk of chronic
diseases in later life.
INTRODUCTION
Women experience various diseases at differ-
ent life stages that correspond to reproductive
health-related events such as menarche and
menopause.1 In particular, postmenarchal
and premenopausal women may develop
oestrogen-dependent diseases such as endo-
metriosis and uterine myoma.2 While some
diseases decline in frequency after meno-
pause, others, such as hyperlipidaemia, occur
more frequently, demonstrating that meno-
pause represents a major transition event in a
woman’s life course.3–5
In women’s health, it is important to under-
stand how the history of gynaecological dis-
eases that occur during premenopausal ages
affects the risk of diseases that occur during
perimenopausal or postmenopausal ages, from
a life-course epidemiological point of view. A
number of previous studies have highlighted
the co-occurrence of gynaecological diseases
with other disorders, such as the increased risk
of ovarian cancer in women with endometri-
osis,6 the association between blood oestrogen
levels and migraine in women,7 8 and the link
between migraine and cardiovascular risk.9
However, few epidemiological studies have
Strengths and limitations of this study
▪ This study examined comprehensively the risks
of comorbidity between early-onset gynaeco-
logical diseases and other subsequent chronic
diseases in later life.
▪ Age at peak incidence for 20 diseases from a
large study population was estimated.
▪ The study population, which was composed
entirely of female nurses, is likely to report disease
history more accurately than general population.
▪ Data on disease histories were collected retro-
spectively, so only living participants were
included in the study.
▪ Women over the age of 60 years were under-
represented relative to other age groups in the
study.
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comprehensively examined the risks of comorbidity
between early-onset gynaecological diseases and other sub-
sequent chronic diseases in later life.
The Japan Nurses’ Health Study ( JNHS) is a large-scale
prospective cohort study investigating the effects of life-
style, healthcare practices and history of diseases on
women’s health.10 In the cross-sectional baseline mail
survey of the study, we investigated the prevalence of past
diagnosis and age at first diagnosis for various diseases.
The study population was designed for female registered
nurses, public health nurses and midwives who were at
least 25 years of age and resident in Japan at the baseline
survey. Nurses were preferred as the study population
because they were expected to accurately report medical
information such as disease history. The objectives of this
study were to classify diseases that occur frequently in
women by identifying age at peak incidence and demon-
strating their co-occurrence with other diseases based on
the JNHS baseline data.
METHODS
Survey participants
The study population comprised 49 927 female nurses who
participated between 2001 and 2007 in the cross-sectional
baseline survey of the JNHS, a nationwide prospective
cohort study. The size of the study population was set to
detect an increase of 1.5 or more in relative risk in the
10-year follow-up phase of the JNHS. The details of the
study plan and the sample size calculation have been pre-
sented elsewhere.5 10 Data were obtained from a self-
administered postal questionnaire covering a range of
health topics including lifestyle habits, disease history,
reproductive health and medication use.10 We included
48 632 women whose responses to the questions on disease
histories were completed. Participants were informed of
the study’s purpose and procedures before recruitment.
Medical history questionnaire
Disease history was ascertained using a questionnaire.
The baseline survey investigated participants’ medical
histories and obtained information on previous diagno-
ses, age at first diagnosis and treatment histories for a
range of major medical disorders.
Diseases analysed and definition of comorbidity
We excluded diseases from the analysis that had a preva-
lence based on the diagnosis history of less than 0.001.
We analysed 20 diseases including hypertension, angina
pectoris, subarachnoid haemorrhage, cerebral infarc-
tion, transient ischaemic attack (TIA), diabetes mellitus,
thyroid disease, hypercholesterolaemia, cholelithiasis,
endometriosis, uterine myoma, cervical cancer, endo-
metrial cancer, ovarian cancer, breast cancer, gastric
cancer, colorectal cancer, osteoporosis, anaemia and
migraine. Comorbidity was defined as the co-occurrence
of two diseases based on a participant’s disease history at
baseline survey regardless of the timing of disease onset.
Statistical analysis
We estimated the cumulative incidence and 95% CI by
the Kaplan-Meier survival analysis (product-limit
method). In the survival analyses, we treated incidence
at the age of first diagnosis as an event in women with a
history of the disease and the observation was censored
at the age recorded in the baseline survey in women
without a history of the disease.11 We estimated the age
at peak incidence using the Kernel smoothing method
(Epanechnikov Kernel) and defined early-onset diseases
(diseases occurring frequently before the perimeno-
pausal period) as those having a peak incidence at less
than 45 years of age.12
To examine the risk of comorbidity between
early-onset diseases and other diseases, ORs and 95%
CIs were calculated. A statistical analysis was conducted
to examine homogeneity by the Breslow-Day test and to
estimate a common OR by the Mantel-Haenszel method
between the two age groups (<50 years or ≥50 years).
The crude ORs were also calculated as part of a sensitiv-
ity analysis. Statistical significance was set at the 5% level
(two tailed) and no adjustments were made for multipli-
city. All analyses were performed using SAS V.9.4 (SAS
Institute Inc., Cary, North Carolina, USA).
RESULTS
Subject characteristics
Of the 49 927 women who participated in the JNHS
baseline survey, 48 632 who responded to the questions
of disease histories were included in the analysis. The
average age (SD) at the time of the baseline survey was
41.2 (7.9) years. The smoking prevalence in the study
population was 17.2% (table 1). In addition, 22.7% of
respondents reported consuming alcoholic beverages
more than three times per week. Most women, 32 642
(67.1%), were married at the time of the baseline survey
and 32 295 (66.4%) were parous. Only 6086 women
(12.5%) were postmenopausal. The average reported
age at menopause (SD) in the postmenopausal women
was 49.1 (4.4) years.
Incidence of past diagnosis by disease
The cumulative incidences estimated by the
Kaplan-Meier method at 30, 40, 50 and 60 years of age
are shown in table 2. The high cumulative incidence at
50 years of age, around the mean age at menopause, was
29.0% for anaemia, 18.9% for uterine myoma, 13.0% for
hypercholesterolaemia, 10.7% for migraine headache,
9.0% for hypertension, 7.4% for endometriosis and
6.0% for thyroid disease.
On the basis of the age at peak incidence of disease
estimated by Kernel smoothing, the early-onset diseases
that had a peak of incidence before 45 years of age
(before the perimenopausal period) were endometriosis
(36 years), anaemia (36 years), migraine headache
(44.8 years), uterine myoma (44.8 years) and cervical
cancer (44.8 years). Figure 1A shows the Kernel
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smoothing estimates of incidence for these early-onset
diseases. The peak incidence of thyroid disease, breast
cancer and cholelithiasis occurred between 45 and
54 years of age, or in the perimenopausal period (figure
1B). For the other 12 diseases (subarachnoid haemor-
rhage, TIA, endometrial cancer, diabetes mellitus, gastric
cancer, cerebral infarction, ovarian cancer, colorectal
cancer, angina pectoris, osteoporosis, hypertension and
hypercholesterolaemia), the peak incidence occurred
after 55 years of age, or in the postmenopausal period
(table 2).
Comorbidity among early-onset diseases
The early-onset diseases were endometriosis, anaemia,
migraine, uterine myoma and cervical cancer. Four
early-onset diseases (endometriosis, anaemia, migraine
headache and uterine myoma) were significantly corre-
lated with one another (table 3). It is worth noting that
the OR (95% CI) for comorbid endometriosis and
uterine myoma was 4.47 (4.09 to 4.87).
Comorbidity of four early-onset diseases and other
diseases
The study population was stratified by age at survey into
two strata, less than 50 years and 50 years of age or older.
Examination for homogeneity of ORs across strata using
the Breslow-Day test revealed that the risk of comorbidity
was statistically heterogeneous for hypertension and
hypercholesterolaemia in women with endometriosis,
diabetes mellitus, osteoporosis, hypertension and hyper-
cholesterolaemia in women with anaemia, thyroid
disease, diabetes mellitus, angina pectoris, hypertension
and hypercholesterolaemia in women with uterine
myoma (table 3). In all of those comorbidities, the OR in
the older age stratum was lower than in the younger age
stratum. The strength of the association was diminished
in the older stratum. The only statistically negative associ-
ation of anaemia and diabetes mellitus was also heteroge-
neous between age strata (Breslow-Day test: p=0.028),
indicating that the negative association was stronger in
the older stratum, with the OR changing from 0.86 in
<50 years to 0.54 in the ≥50 years of age stratum.
The common ORs (95% CI) greater than 2.00 for
comorbid endometriosis were 3.65 (2.16 to 6.19), 2.40
(1.14 to 5.04) and 2.10 (1.15 to 3.85) for ovarian cancer,
endometrial cancer and cerebral infarction, respectively.
The common OR greater than 2.00 for comorbid
anaemia was 3.69 (2.68 to 5.08) for gastric cancer.
The common OR for comorbid anaemia and diabetes
mellitus was significantly lower, 0.68 (0.56 to 0.84). The
common ORs greater than 2.00 for comorbid migraine
headache were 3.06 (2.29 to 4.09), 2.11 (1.71 to 2.62),
2.04 (1.26 to 3.30) and 2.00 (1.49 to 2.67) for TIA,
osteoporosis, cerebral infarction and angina pectoris,
respectively. The common OR greater than 2.00 for
comorbid uterine myoma was 2.31 (1.48 to 3.61) for
colorectal cancer only (table 3). The crude ORs without
stratification were used in a sensitivity analysis. Similar
estimates were obtained (data not shown).
DISCUSSION
The age at peak incidence of diseases in Japanese women
varies in the premenopausal, perimenopausal and post-
menopausal periods. The early-onset diseases (those with
a peak incidence before 45 years of age) were endometri-
osis, anaemia, migraine headache, uterine myoma and
cervical cancer. The associations found in this compre-
hensive study between early-onset diseases and other dis-
eases suggest that women with a history of early-onset
diseases have a higher risk of other diseases later in their
life course. Understanding the history of early-onset dis-
eases in women may help reduce any subsequent risk of
chronic diseases in later life.
Table 1 Characteristics of study population at baseline
survey
Characteristics N Proportion (%)
Age (year)
<30 938 1.9
30–34 11 174 23.0








Non-smoker 33 918 69.7




Non-drinker 14 224 29.2
<3 day/week 20 391 41.9
≥3 day/week 11 024 22.7
Missing 2993 6.2
Marital status
Unmarried 11 633 23.9





Never 12 786 26.3
Ever 33 618 69.1
Missing 2228 4.6
Delivery
Never 14 328 29.5
Ever 32 295 66.4
Missing 2009 4.1
Menopause status
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In this study, we observed a skewed age distribution
because of the smaller sample size of participants aged
50 years or older. We stratified the study population by
age at the time of the survey into two strata (<50 years
and ≥50 years of age) and examined the homogeneity
of ORs between the age groups. In addition, we esti-
mated the common ORs between the two age groups
instead of overall crude ORs to adjust for the skewed age
distribution. However, statistical significance in the
comorbidity of very late-onset diseases such as osteopor-
osis was unlikely because of the small sample size in the
older age group.
For endometriosis, the estimated age at peak inci-
dence was 36 years of age and the cumulative incidence
at 50 years of age was 7.4%; thus, endometriosis could
be considered a common gynaecological disorder in
relatively young women. Endometriosis is characterised
by excessive growth of extrauterine endometrial tissue,
resulting in subsequent bleeding into the abdominal
cavity and ovaries, and presenting with symptoms such
as peritonitis and painful defaecation or urination.
While levels of high-sensitivity C reactive protein (CRP),
a marker of inflammation, have been found to be signifi-
cantly higher in women with endometriosis,13 other
studies have reported an association between elevated
blood levels of high-sensitivity CRP and ischaemic
stroke.14 15 Inflammation resulting from endometriosis
may therefore also be linked with an increased risk of
ischaemic stroke. Our results suggest that endometriosis
may increase the risk of cerebral infarction and TIA by
triggering inflammation. The OR (95% CI) for
comorbid endometriosis and ovarian cancer was 3.65
(2.16 to 6.19), which supports the conclusions of a previ-
ous study that found that endometriosis increases the
risk of developing ovarian cancer.6
Anaemia was found to have a higher cumulative inci-
dence (29.0% at 50 years of age). Anaemia is highly
prevalent among women and may be diagnosed follow-
ing pregnancy or heavy menstrual bleeding caused by
uterine myoma. In the present study, the peak incidence
for anaemia occurred at 36 years of age. Our results
imply that relatively young, premenopausal women are
more susceptible to anaemia than older, postmenopau-
sal women. Our results also suggest a strong association
between anaemia and gastric cancer. While anaemia can
occur because of gastrectomy,16 pernicious anaemia is
associated with increased risk of gastric cancer.17–19 The
causal pathway, including a reverse effect, could not be
determined because of the study’s cross-sectional design.
This study had a novel finding in that there was a signifi-
cant negative association between anaemia and diabetes
mellitus. Several studies have reported that body iron
stores or elevated ferritin concentrations were associated
with increased risk of type 2 diabetes mellitus,20 21
potentially supporting our finding of the negative associ-
ation between anaemia and diabetes mellitus.
The age at incidence peak of migraine headache was
44.8 years. Several studies reported that migraine was
associated with oestrogen levels,7 8 and the incidence sig-
nificantly increased from menarche onwards.22 23
Migraine also increased the risk of ischaemic stroke and
cardiovascular disease in another study.9 This study’s
findings of a significantly enhanced risk of TIA, cerebral
infarction and angina pectoris in migraine sufferers
appear to support this.
The cumulative incidence at 50 years of age of uterine
myoma was 18.9%. Although uterine myoma is often
asymptomatic, we diagnosed a number of participants
with the condition after they underwent cancer screen-
ing or a prenatal test. Uterine myoma is associated with
elevated body mass index24 and body fat percentage,25
suggesting that uterine myoma may be associated with
obesity. Obesity is also associated with increased risk of
colon cancer.26 27 The OR of comorbid colorectal
cancer was 2.31 (1.48 to 3.61) in this study, suggesting
that obesity is a potential common risk factor for uterine
myoma and colorectal cancer.
The estimated age at peak incidence of early-onset dis-
eases, as well as other diseases in this study, revealed the
nature of diseases in a woman’s life course. The diseases
Figure 1 (A) Kernel smoothing estimates of incidence for
early-onset diseases with a peak incidence before 45 years of
age. (B) Kernel smoothing estimates of incidence for diseases
with a peak incidence between 45 and 54 years of age.
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included hypercholesterolaemia, hypertension and
osteoporosis, which occur more frequently among post-
menopausal women over 60 years of age. The cumulative
incidences at 60 years of age for hypercholesterolaemia,
hypertension and osteoporosis were 41.3%, 23.4% and
6.7%, respectively, and these diseases exhibited a
marked increase in incidence after the perimenopausal
period.
The peak incidence for breast cancer occurred at
50 years (figure 1B), indicating that Japanese women
are more likely to develop the disease before menopause
rather than after the perimenopausal period. Our
results suggest that, unlike women in Western countries
where the incidence of breast cancer increases with age
even after menopause,28 the incidence among women
in Japan and other Asian settings exhibits a bell-shaped
pattern with a peak at 45–50 years.29 Our findings there-
fore support the current consensus that the incidence of
breast cancer in Japan is higher before menopause than
after.
This study has several limitations. In this study, we
defined disease onset as a diagnosis by a medical
doctor that was reported on the self-administered ques-
tionnaire. Participants could only report a diagnosis;
asymptomatic or undiagnosed diseases were excluded.
Use of diagnoses rather than self-reported prevalence
may affect correlation in some diseases. Information on
disease diagnosis was based on self-reporting, which
may have led to a misclassification of diagnoses.
However, nurses are likely to report such information
more accurately than the general population because
of their medical knowledge and clinical experience. In
addition, our study population, which was composed
entirely of nurses, was likely to exhibit different health
behaviours and be exposed to different risk factors
compared with the general Japanese population. Thus,
our findings may not be generalisable to the national
population, reducing this study’s external validity.
However, we have no reason to suspect that the general
population of women would differ in terms of risk of
comorbidity between early-onset and other diseases
later in the life course. Additionally, data on disease his-
tories were collected retrospectively, so only living parti-
cipants were included in the survey. This may have
led to an underestimation of disease incidence.
Furthermore, we were unable to determine the causal
relationship between comorbidities because of the
cross-sectional design. Recall bias may have caused an
overestimation of ORs since sick people tend to report
more about disease history. However, since the partici-
pants were nurses, we think that recall bias was mini-
mised since they have medical knowledge and are more
likely to have answered correctly. A further analysis of
the JNHS cohort using follow-up data is needed to
determine the causal relationships between these
comorbidities. Finally, women over the age of 60 years
were under-represented relative to other age groups in
the study.
CONCLUSIONS
While there were significant associations between the
four early-onset diseases (endometriosis, anaemia,
migraine headache and uterine myoma), women with a
history of early-onset diseases had a higher risk of other
diseases later in the life course. Understanding the
history of early-onset diseases in women may help
reduce the subsequent risk of chronic diseases in later
life. Further research based on follow-up studies is
needed to clarify the cause–effect associations between
these diseases.
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